41 |
|
An in-vitro model of microbial growth in the infected dialysed poritoneal cavity
|
Brant, J. A
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
42 |
|
An in-vitro study of the effect of hydrocolloid patch occlusion on the penetration of triamcinolone acetonide through skin in man
|
Ladenheim, D
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
43 |
|
An in-vivo investigation of lectin retention within the precorneal region
|
Nicholls, T. J
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
44 |
|
An optimized derivatization method for the screening of anabolic steroids
|
Udoh, E. E
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
45 |
|
Antagonistic effects of OPC-14597, a novel antipsychotic drug, on quinpirole- and (-)-sulpiride-induced changes in evoked dopamine release in ratstriatal slices
|
Yamada, S
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
46 |
|
Antibacterial action of nitrofurantoin against Escherichia coli when protein synthesis, RNA synthesis, or cell division are inhibited
|
Sharpe, C. A
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
47 |
|
Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant staphylococcus aureus
|
Iinuma, M
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
48 |
|
Anticholinergic activity in mice and receptor-binding properties in ratsof a series of synthetic tropane derivatives
|
Gao, Z. G
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
49 |
|
Antidiabetic efficacy of BRL 49653, a potent orally active insulin sensitizing agent, assessed in the C57BL/KsJ db/db diabetic mouse by non-invasive ^1H NMR studies of urine
|
Connor, S. C
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
50 |
|
Antidiarrhoeal activity of new thiazolidinones related to loperamide
|
Diurno, M. V
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
51 |
|
Antifungal activity of extracts of Bignoniaceae from Malaysia
|
Houghton, P. J
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
52 |
|
Antihypertensive drugs reduce noradrenaline-induced hypertrophy of cultured yocardial cells
|
Laehteenmaeki, T. A
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
53 |
|
Antihypertensive Effect of some Oxazolo[3,2-a]pyridines, Thiazolo[3,2-a]pyridines and Pyrido[2,1-b]oxazines in Conscious Spontaneously Hypertensive Rats
|
Moran, A
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
54 |
|
Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems
|
Conforti, A
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
55 |
|
Anti-inflammatory, analgesic and ulcerogenic properties of S-(+)-ibuproxam, racemic ibuproxam-�cyclodextrin and S-(+)-ibuproxam-�cyclodextrin
|
Bole-Vunduk, B
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
56 |
|
Antileishmanial activity of Kigelia pinnata root bark constituents
|
Moideen, S. V. K
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
57 |
|
Antimalarial agents directed at thymidylate synthase
|
Rathod, P. K
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
58 |
|
Antimalarial endoperoxides that are potent and easily synthesized
|
Posner, G. H
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
59 |
|
Antimicrobial activity of electrochemical silver ions in nonionic surfactant solutions and in model dispersions
|
Scalzo, M
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
60 |
|
Antimicrobial Susceptibility Testing. Critical Issues for the 90s
|
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|